Navigation Links
Ventria's Child Health Product Recognized for Its Promise
Date:11/12/2007

SACRAMENTO, Calif., Nov. 12 /PRNewswire/ -- A review article published in the Journal of Infection entitled, "Advances in defining etiology and new therapeutic approaches in acute diarrhea" [1], recognized Ventria's Child Health Product for its benefit to children who are suffering from acute diarrhea. The review was published online and is also available in the November print version.

Ventria's product is a medical food which can be added to standard electrolyte solutions to help children get better faster. The product was designed by researchers studying the advantages of breastfeeding for children. Ventria developed a method to affordably manufacture the important nutritional components of breast milk in rice. By replenishing these nutritional components, children suffering from diarrhea recovered quicker by one and a half days compared to the current standard electrolyte product used for rehydration during diarrhea.

William Greenough III, MD, Professor of Medicine at Johns Hopkins University and a world-renowned expert in pediatric diarrhea said "I am hoping that Ventria's product might be the first improvement that would be widely added to oral hydration solutions, which are consumed by at least half of the world's children".

In the United States there are an estimated 4.5 million hospital visits for childhood diarrhea. Globally, childhood diarrhea is the second leading killer of children under the age of 5, claiming 2 million lives annually.

"Diarrheal illnesses are a major reason for children seeing their physician and a major cause of emergency room visits," said Robert Wittler, MD, Professor, Pediatric Infectious Diseases, Kansas University School of Medicine at Wichita. "Oral rehydration is a safe and effective way to treat most diarrheal illnesses and this study confirms the advantages of adding proteins contained in breast milk to oral rehydration solution. This is an important study as decreasing the duration of diarrhea lessens the likelihood of children becoming significantly dehydrated and allows children to return to daycare and school quicker and their parents who work outside the home can return to work sooner."

"Ventria has been developing this product for several years and we are pleased with the recognition from leaders in the medical community. We anticipate a successful market introduction of this product so that we can make a positive contribution to child health on a global basis." said Scott Deeter, President and CEO, Ventria Bioscience.

(1) Marcos, L, Dupont, H

Advances in defining etiology and new therapeutic approaches in acute

diarrhea.

Journal of Infection. 2007 55, 385-393

For more information, see our website at Ventria Bioscience

http://www.ventria.com

Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.


'/>"/>
SOURCE Ventria Bioscience
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Children of depressed moms do better when dad is involved, SLU researcher finds
2. High pollution linked to poor lung function growth in children in Mexico City
3. Genetic predisposition increases childhood asthma risk
4. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
5. Obese Children Miss More School Days
6. Treating diabetes during pregnancy can break link to childhood obesity
7. Ultra-Runner to Run 63 Marathons in 63 Days for Children with Incurable Disease
8. Chinas 1-child policy could backfire on its elderly
9. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
10. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
11. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... ... How to Write Error Free Procedures, **Presented by Ginette M. Collazo and ... known to be the major cause of quality and production losses in many industries. ... performance problems can be prevented. , How to Write Error Free Procedures, part two ...
(Date:5/24/2016)... CA (PRWEB) , ... May 24, 2016 , ... Loma ... house the new adult hospital and expanded Children’s Hospital. Over 3,000 people looked on ... , Check out the event photo slidehsow. , During the program, Richard ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... freezing, today announced the official relaunch of its community and education hub for ... eggs. Eggsurance's mission is to create a safe and welcoming place for women ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Tuesday, May 24, ... The Yoga practice enhanced with Young Living Essential Oils, taught by Patti Dolan, RYT, ... the Lake Orion location. Yoga Flow is 6:30pm - 7:15pm followed by a small ...
(Date:5/24/2016)... DeLand, Florida (PRWEB) , ... May 24, 2016 , ... ... to make residents aware of the potential of contaminated well water throughout the Houston ... is homes supplied with well water that’s exposed to contaminants. Residents may not even ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... 24, 2016 The innovator ... , s first dual therapy stent, introduces ... OrbusNeich, a global company specializing in the ... to include products to treat peripheral artery disease. The ... entry devices for lower limb and arteriovenous (AV) fistula ...
(Date:5/24/2016)... 24, 2016 ... , la première endoprothèse à double thérapie ... l,intervention portant sur les membres inférieurs et ... OrbusNeich, entreprise mondiale spécialisée dans la fourniture ... vie, a élargi son portefeuille pour inclure ...
Breaking Medicine Technology: